A multicenter case control study of association of vitamin D with breast cancer among women in Karachi, Pakistan.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
24
05
2019
accepted:
04
11
2019
entrez:
23
1
2020
pubmed:
23
1
2020
medline:
1
4
2020
Statut:
epublish
Résumé
The prevalence of vitamin D inadequacy and breast cancer are both high among women living in Karachi, Pakistan. A matched case control study was conducted in two hospitals of Karachi, Pakistan to evaluate the association of vitamin D (serum 25-hydroxyvitamin D) concentrations, vitamin D supplementation and sun exposure with breast cancer among Pakistani women. A total of 411 newly diagnosed histologically confirmed primary breast cancer cases were enrolled and 784 controls, free of breast and any other cancers, were matched by age (year of birth ± 5 years), residence in the same geographic area and study site. Information was collected on sociodemographic history, history of vitamin D supplementation, past medical and obstetrical history, family history of breast cancer, sun exposure history, histopathology reports and anthropometric measurement and venous blood was collected to measure serum 25-hydroxyvitamin D (25(OH)D) concentration. Compared to patients with sufficient serum vitamin D (>30 ng/ml), women with serum vitamin D deficiency (<20ng/ml), had a higher risk of breast cancer (OR = 1.65, 95%CI: 1.10, 2.50). Women with history of vitamin D supplementation one year prior to enrollment, had significant protective effect against breast cancer (OR = 0.32, 95% CI: 0.24, 0.43). Serum vitamin D deficiency was associated with increased risk of breast cancer, while vitamin D supplementation was associated with decreased risk of breast cancer. In Pakistani women, where vitamin D deficiency is common, raising and maintaining serum vitamin D at population level is a safe and affordable strategy. It may play a role in reducing the incidence of both vitamin D deficiency and breast cancer, particularly among poor women where the breast cancer mortality is highest due to limited resources for early detection, diagnosis, and treatment. The effects of vitamin D with regard to breast cancer risk in Karachi Pakistan should be further evaluated.
Sections du résumé
BACKGROUND
The prevalence of vitamin D inadequacy and breast cancer are both high among women living in Karachi, Pakistan.
METHODS
A matched case control study was conducted in two hospitals of Karachi, Pakistan to evaluate the association of vitamin D (serum 25-hydroxyvitamin D) concentrations, vitamin D supplementation and sun exposure with breast cancer among Pakistani women. A total of 411 newly diagnosed histologically confirmed primary breast cancer cases were enrolled and 784 controls, free of breast and any other cancers, were matched by age (year of birth ± 5 years), residence in the same geographic area and study site. Information was collected on sociodemographic history, history of vitamin D supplementation, past medical and obstetrical history, family history of breast cancer, sun exposure history, histopathology reports and anthropometric measurement and venous blood was collected to measure serum 25-hydroxyvitamin D (25(OH)D) concentration.
RESULTS
Compared to patients with sufficient serum vitamin D (>30 ng/ml), women with serum vitamin D deficiency (<20ng/ml), had a higher risk of breast cancer (OR = 1.65, 95%CI: 1.10, 2.50). Women with history of vitamin D supplementation one year prior to enrollment, had significant protective effect against breast cancer (OR = 0.32, 95% CI: 0.24, 0.43).
CONCLUSIONS AND RECOMMENDATION
Serum vitamin D deficiency was associated with increased risk of breast cancer, while vitamin D supplementation was associated with decreased risk of breast cancer. In Pakistani women, where vitamin D deficiency is common, raising and maintaining serum vitamin D at population level is a safe and affordable strategy. It may play a role in reducing the incidence of both vitamin D deficiency and breast cancer, particularly among poor women where the breast cancer mortality is highest due to limited resources for early detection, diagnosis, and treatment. The effects of vitamin D with regard to breast cancer risk in Karachi Pakistan should be further evaluated.
Identifiants
pubmed: 31967989
doi: 10.1371/journal.pone.0225402
pii: PONE-D-19-14423
pmc: PMC6975526
doi:
Substances chimiques
Vitamin D
1406-16-2
25-hydroxyvitamin D
A288AR3C9H
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0225402Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Coll Physicians Surg Pak. 2018 Feb;28(2):87-88
pubmed: 29394963
Eur J Cancer. 2008 Jul;44(11):1485-7
pubmed: 18479909
PLoS One. 2018 Jun 15;13(6):e0199265
pubmed: 29906273
Int J Cancer. 2011 Mar 15;128(6):1425-33
pubmed: 20473950
J Steroid Biochem Mol Biol. 2018 Jan;175:55-59
pubmed: 27687737
Carcinogenesis. 2012 Jul;33(7):1319-26
pubmed: 22623648
Nat Rev Cancer. 2014 May;14(5):342-57
pubmed: 24705652
BMJ. 2018 Mar 7;360:k671
pubmed: 29514781
Nutr Clin Pract. 2007 Jun;22(3):305-22
pubmed: 17507731
Med Sci Monit. 2014 May 19;20:818-24
pubmed: 24835144
Cancer Causes Control. 2014 Jul;25(7):819-27
pubmed: 24748579
Breast Cancer Res. 2009;11(4):R64
pubmed: 19715600
Indian J Endocrinol Metab. 2012 May;16(3):409-13
pubmed: 22629509
PLoS One. 2011 Feb 28;6(2):e17251
pubmed: 21386992
J Steroid Biochem Mol Biol. 2018 Apr;178:348-353
pubmed: 29438722
Tumour Biol. 2013 Dec;34(6):3509-17
pubmed: 23807676
Integr Cancer Ther. 2018 Jun;17(2):217-225
pubmed: 28589744
Cancer Res. 2016 Sep 15;76(18):5423-30
pubmed: 27530324
BMC Public Health. 2010 Aug 29;10:519
pubmed: 20799984
PLoS One. 2014 Jan 21;9(1):e86467
pubmed: 24466109
J Pain Symptom Manage. 2013 Jun;45(6):1094-106
pubmed: 23017628
BMJ. 2014 Apr 01;348:g2035
pubmed: 24690624
Gynecol Obstet Fertil. 2013 Apr;41(4):242-50
pubmed: 23562418
Nutr Cancer. 2013;65(2):178-87
pubmed: 23441605
Breast Cancer Res Treat. 2010 Aug;123(1):233-43
pubmed: 20130986
Breast Cancer Res Treat. 2012 Apr;132(2):683-91
pubmed: 22130867
Br J Cancer. 2014 May 27;110(11):2772-84
pubmed: 24714744
PLoS Med. 2007 Oct 16;4(10):e296
pubmed: 17941714
Anticancer Res. 2006 Jul-Aug;26(4A):2573-80
pubmed: 16886666
Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1991-7
pubmed: 16103450
Am J Clin Nutr. 2007 Jun;85(6):1586-91
pubmed: 17556697
BMC Public Health. 2012 Jun 08;12:421
pubmed: 22682277
J Steroid Biochem Mol Biol. 2008 Sep;111(3-5):195-9
pubmed: 18590821
Am J Clin Nutr. 2014 Nov;100(5):1361-70
pubmed: 25332334
J Clin Oncol. 2016 Jan 1;34(1):6-13
pubmed: 26578608
Breast Cancer Res Treat. 2012 Nov;136(1):309-12
pubmed: 22872547
J Pak Med Assoc. 2015 Nov;65(11):1247-50
pubmed: 26564307
Eur J Cancer. 2010 Aug;46(12):2196-205
pubmed: 20456946
Ann Oncol. 2009 Feb;20(2):374-8
pubmed: 18711029
Anticancer Res. 2015 Feb;35(2):1153-60
pubmed: 25667506
J Nutr. 2011 Aug;141(8):1524-8
pubmed: 21697301
Medicine (Baltimore). 2013 May;92(3):132-4
pubmed: 23619237
Endocrinology. 2007 Oct;148(10):4887-94
pubmed: 17628009
J Steroid Biochem Mol Biol. 2018 Sep;182:4-13
pubmed: 29679754
Chin Med J (Engl). 2017 May 5;130(9):1074-1078
pubmed: 28469103
Vitam Horm. 2016;100:83-116
pubmed: 26827949
Breast Cancer Res Treat. 2015 Jul;152(1):147-154
pubmed: 26037255
Cancer Prev Res (Phila). 2009 Jun;2(6):598-604
pubmed: 19470790
Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2341-50
pubmed: 20826834
Front Endocrinol (Lausanne). 2018 Jul 17;9:373
pubmed: 30065699
Anticancer Res. 2016 Mar;36(3):1357-70
pubmed: 26977037
Am J Clin Nutr. 2010 Jun;91(6):1699-707
pubmed: 20392891
Clin Breast Cancer. 2017 Nov;17(7):559-563
pubmed: 28601383
Cancers (Basel). 2013 Nov 05;5(4):1439-55
pubmed: 24202453
Cancer Causes Control. 2007 Sep;18(7):775-82
pubmed: 17549593
Ann Surg Oncol. 2012 Aug;19(8):2590-9
pubmed: 22446898
Am J Epidemiol. 2012 Apr 1;175(7):673-84
pubmed: 22362582
Breast Cancer Res. 2013 Feb 26;15(1):R15
pubmed: 23442740
Breast Cancer Res Treat. 2010 Jun;121(2):469-77
pubmed: 19851861
N Engl J Med. 2007 Jul 19;357(3):266-81
pubmed: 17634462
Anticancer Res. 2013 Feb;33(2):543-51
pubmed: 23393347
Arch Intern Med. 2008 Jun 23;168(12):1340-9
pubmed: 18574092
Pak J Med Sci. 2017 May-Jun;33(3):645-649
pubmed: 28811787
Mol Aspects Med. 2008 Dec;29(6):361-8
pubmed: 18801384
Int J Cancer. 2011 Mar 15;128(6):1414-24
pubmed: 20473927
Asian Pac J Cancer Prev. 2014;15(8):3391-6
pubmed: 24870727
Breast Cancer Res Treat. 2012 Jun;133(3):1077-88
pubmed: 22415479
Int J Cancer. 2000 Feb 1;85(3):325-9
pubmed: 10652421
Epidemiology. 2012 Jan;23(1):159-64
pubmed: 22081062
Environ Health Perspect. 2017 Jul 06;125(7):077004
pubmed: 28728134
J Natl Cancer Inst. 2019 Feb 1;111(2):158-169
pubmed: 29912394
N Engl J Med. 2008 Jan 17;358(3):213-6
pubmed: 18199859
Proc Natl Acad Sci U S A. 2017 Mar 14;114(11):E2186-E2194
pubmed: 28242709
Rev Endocr Metab Disord. 2017 Jun;18(2):153-165
pubmed: 28516265
Arch Endocrinol Metab. 2018 Aug;62(4):452-459
pubmed: 30304110
Eur J Epidemiol. 2016 Mar;31(3):311-23
pubmed: 25977096
Ecancermedicalscience. 2013 Oct 23;7:365
pubmed: 24171049
J Am Coll Nutr. 2016 Sep-Oct;35(7):639-646
pubmed: 27331363
J Natl Cancer Inst. 2008 Nov 19;100(22):1581-91
pubmed: 19001601
Am J Clin Nutr. 2011 Oct;94(4):1144-9
pubmed: 21880848
Mayo Clin Proc. 2013 Jul;88(7):720-55
pubmed: 23790560
Cancer. 2002 Jan 1;94(1):272-81
pubmed: 11815987
Autoimmun Rev. 2013 Aug;12(10):976-89
pubmed: 23542507
Clin Med Insights Womens Health. 2018 Apr 03;11:1179562X18767884
pubmed: 29662333
J Natl Cancer Inst. 1998 Mar 18;90(6):461-3
pubmed: 9521171
Int J Cancer. 2013 Oct 1;133(7):1689-700
pubmed: 23526380
Mol Cell Endocrinol. 2003 Feb 28;200(1-2):67-80
pubmed: 12644300
Am J Epidemiol. 2010 Apr 15;171(8):903-8
pubmed: 20219763
Medicine (Baltimore). 2013 May;92(3):123-31
pubmed: 23625163
Arch Osteoporos. 2017 Dec;12(1):34
pubmed: 28378273
Int J Epidemiol. 1990 Dec;19(4):820-4
pubmed: 2084008
Am J Clin Nutr. 2015 Oct;102(4):966-73
pubmed: 26354532
J Steroid Biochem Mol Biol. 2018 Jan;175:200-204
pubmed: 29137944
PLoS One. 2012;7(3):e33452
pubmed: 22457762
Int J Cancer. 2009 Jan 1;124(1):250-5
pubmed: 18839430
J Clin Endocrinol Metab. 2016 Jan;101(1):33-43
pubmed: 26509869
Asian Pac J Cancer Prev. 2015;16(17):7473-8
pubmed: 26625747
Environ Int. 2019 Jan;122:67-90
pubmed: 30509511
Breast Cancer Res. 2011 May 11;13(3):R50
pubmed: 21569367
Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):889-94
pubmed: 18381472
Lancet Diabetes Endocrinol. 2014 Jan;2(1):76-89
pubmed: 24622671
J Ayub Med Coll Abbottabad. 2014 Apr-Jun;26(2):186-90
pubmed: 25603674
J Clin Oncol. 2009 May 1;27(13):2151-6
pubmed: 19349547
PLoS One. 2013;8(1):e49312
pubmed: 23382798